Indutrade AB (publ) (INDT)
Free
No email, no account, no signup.
Pulling latest news for Indutrade AB (publ)…
Bull
Bear
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99 $1.25.
Get the deep 4-model report – Signal
HOLD
Sentiment
5/10
Risk
6/10
Get full analysis with Bull/Bear case, catalysts, and risk analysis
Buy express analysis –
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Sentiment remains weak after Q1 and the sell-off, but is slightly supported/stabilised by Lundbergs’ large purchase and S&P’s more positive credit outlook; the market still focuses on low organic growth and margin pressure.
Exchange
Nasdaq Stockholm
Type
Industrials
Sector
Technical trading and industrial components
Market Cap
$8.1B
Market sentiment
Sentiment remains weak after Q1 and the sell-off, but is slightly supported/stabilised by Lundbergs’ large purchase and S&P’s more positive credit outlook; the market still focuses on low organic growth and margin pressure.
Why HOLD ?
Hold: high-quality compounder with solid cash generation and ongoing M&A capacity, but Q1 confirmed weak organic momentum and some margin pressure, increasing the risk of near-term multiple compression. Wait for clearer signs of organic recovery/margin stabilization or a more attractive entry point.
- Maintain the position; consider adding only after clearer organic improvement (over multiple quarters) or at a more attractive valuation following report-driven weakness. If portfolio weight is high, a small trim can be considered to manage near-term reporting/margin risk.
Recent News
- Since the last analysis (2026-05-16), Indutrade has continued its acquisition pace: acquisition of Valveco B.V. (Netherlands, flow technology, ~SEK 345m revenue; closing May 27; Process, Energy & Water; marginally positive EPS impact) and acquisition of Createc (Germany, composite components, ~SEK 250m revenue; Life Science). The share has continued to trade below the 50/200-day moving averages and sentiment appears weak-to-neutral ahead of the Q2 report on 16 July 2026.
Bull case
- The **Q1 report** could show stabilization in organic sales and margins.
- Continued **strong cash generation** and a defensive profile may support the share.
Unlock to read more →
Bear case
- Ongoing **weak organic growth** could pressure valuation.
Unlock to read more →
Catalysts
16 Jul 2026 — Q2 / Half-year report 2026
Dilution Risk
Assessment: Low
Order analysis – $4.99 $1.25
Save hours of research. $4.99 $1.25.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Want to read the full analysis?
Order a fresh analysis of Indutrade AB (publ) – ready in your inbox in 5–15 minutes.
- Signal + risk + sentiment
- Bull/Bear case + triggers
- Catalysts with dates
- Saved as a webpage in your account
- Ready in 5–15 min (email when ready)
Full analysis at introductory pricing — 7-day money-back guarantee.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Fact-based analysis
Updated weekly
No commitment period
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.